On September 18, the SENSOPAD project officially launched with a Kick-Off Meeting (KoM) in Athens, Greece, hosted at the National Technical University of Athens (NTUA), the premises of the project’s coordinator. Over the next four years, SENSOPAD aims to research and develop tools for the early diagnosis of endometriosis, a condition that has historically been difficult to detect, often leaving women without proper support for years.
SENSOPAD introduces an innovative, non-invasive approach to monitoring vital biomarkers during the menstrual cycle. The project will develop:
- A smart sanitary pad that detects key biomarkers linked to endometriosis.
- A portable diagnostic device for in-depth, real-time analysis.
- A user-friendly mobile application that provides women with insights into their menstrual health and potential early signs of endometriosis.
These advancements aim to empower women with accessible, at-home monitoring tools, facilitating earlier diagnosis and improving disease management.
The KoM brought together 14 project partners from across Europe and the UK, hosting discussions on the project’s objectives, methodologies, and expected impact. The meeting served as a platform to align on technical developments, research frameworks, and implementation strategies that will guide SENSOPAD throughout its duration, from September 2024 to August 2028.
The consortium’s multidisciplinary expertise – spanning biomedical engineering, clinical research, data science, and digital health solutions – will be fundamental in driving the project forward.
The SENSOPAD project marks a significant step toward improving healthcare accessibility and early intervention for those affected by endometriosis. As the project progresses, updates on research findings, technological developments, and key milestones will be shared with the broader community.
Stay connected to follow the journey toward a more effective, accessible, and patient-centered approach to endometriosis care.